{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:32Z","timestamp":1707524492679},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,21]]},"DOI":"10.7759\/cureus.23374","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T21:50:50Z","timestamp":1647899450000},"source":"Crossref","is-referenced-by-count":1,"title":["Early Diagnosis of V180I Genetic Creutzfeldt-Jakob Disease at the Preserved Cognitive Function Stage"],"prefix":"10.7759","author":[{"given":"Yutaro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuyuki","family":"Kitamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner SB","year":"1998","unstructured":"Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998, 95:13363-83. 10.1073\/pnas.95.23.13363","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kov\u00e1cs GG","year":"2005","unstructured":"Kov\u00e1cs GG, Puopolo M, Ladogana A, et al.. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005, 118:166-74. 10.1007\/s00439-005-0020-1","journal-title":"Hum Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq216","article-title":"Prospective 10-year surveillance of human prion diseases in Japan","volume":"133","author":"Nozaki I","year":"2010","unstructured":"Nozaki I, Hamaguchi T, Sanjo N, et al.. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010, 133:3043-57. 10.1093\/brain\/awq216","journal-title":"Brain"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000106954.54011.80","article-title":"Clinical features of Creutzfeldt-Jakob disease with V180I mutation","volume":"62","author":"Jin K","year":"2004","unstructured":"Jin K, Shiga Y, Shibuya S, et al.. Clinical features of Creutzfeldt-Jakob disease with V180I mutation. Neurology. 2004, 62:502-5. 10.1212\/01.wnl.0000106954.54011.80","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004968","article-title":"Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene","volume":"4","author":"Qina T","year":"2014","unstructured":"Qina T, Sanjo N, Hizume M, et al.. Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open. 2014, 4:e004968. 10.1136\/bmjopen-2014-004968","journal-title":"BMJ Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000254842","article-title":"Familial Creutzfeldt-Jakob disease with a V180I mutation: comparative analysis with pathological findings and diffusion-weighted images","volume":"28","author":"Mutsukura K","year":"2009","unstructured":"Mutsukura K, Satoh K, Shirabe S, et al.. Familial Creutzfeldt-Jakob disease with a V180I mutation: comparative analysis with pathological findings and diffusion-weighted images. Dement Geriatr Cogn Disord. 2009, 28:550-7. 10.1159\/000254842","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005779","article-title":"Teaching neuroimages: cerebral cortex swelling in Creutzfeldt-Jakob disease with V180I mutation","volume":"91","author":"Sugiyama A","year":"2018","unstructured":"Sugiyama A, Beppu M, Kuwabara S. Teaching neuroimages: cerebral cortex swelling in Creutzfeldt-Jakob disease with V180I mutation. Neurology. 2018, 91:e185-6. 10.1212\/WNL.0000000000005779","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-019-1120-4","article-title":"Validation of Addenbrooke's cognitive examination III for detecting mild cognitive impairment and dementia in Japan","volume":"19","author":"Takenoshita S","year":"2019","unstructured":"Takenoshita S, Terada S, Yoshida H, et al.. Validation of Addenbrooke's cognitive examination III for detecting mild cognitive impairment and dementia in Japan. BMC Geriatr. 2019, 19:123. 10.1186\/s12877-019-1120-4","journal-title":"BMC Geriatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70049-3","article-title":"Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial","volume":"8","author":"Collinge J","year":"2009","unstructured":"Collinge J, Gorham M, Hudson F, et al.. Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol. 2009, 8:334-44. 10.1016\/S1474-4422(09)70049-3","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00488-7","article-title":"The importance of ongoing international surveillance for Creutzfeldt-Jakob disease","volume":"17","author":"Watson N","year":"2021","unstructured":"Watson N, Brandel JP, Green A, et al.. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat Rev Neurol. 2021, 17:362-79. 10.1038\/s41582-021-00488-7","journal-title":"Nat Rev Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.04.004","article-title":"Early detection of familial Creutzfeldt-Jakob disease on diffusion-weighted imaging before symptom onset","volume":"319","author":"Terasawa Y","year":"2012","unstructured":"Terasawa Y, Fujita K, Izumi Y, Kaji R. Early detection of familial Creutzfeldt-Jakob disease on diffusion-weighted imaging before symptom onset. J Neurol Sci. 2012, 319:130-2. 10.1016\/j.jns.2012.04.004","journal-title":"J Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24757","article-title":"Long-term preclinical magnetic resonance imaging alterations in sporadic Creutzfeldt-Jakob disease","volume":"80","author":"Zanusso G","year":"2016","unstructured":"Zanusso G, Camporese G, Ferrari S, et al.. Long-term preclinical magnetic resonance imaging alterations in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2016, 80:629-32. 10.1002\/ana.24757","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13807","article-title":"Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease","volume":"25","author":"Novi G","year":"2018","unstructured":"Novi G, Canosa A, Nobili F, Bongianni M, Zanusso G, Balestrino M, Roccatagliata L. Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease. Eur J Neurol. 2018, 25:e127-8. 10.1111\/ene.13807","journal-title":"Eur J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1155-18","article-title":"Cortical hyperintensity on diffusion-weighted images as the presymptomatic marker of sporadic Creutzfeldt-Jakob disease","volume":"58","author":"Maeda K","year":"2019","unstructured":"Maeda K, Sugihara Y, Shiraishi T, Hirai A, Satoh K. Cortical hyperintensity on diffusion-weighted images as the presymptomatic marker of sporadic Creutzfeldt-Jakob disease. Intern Med. 2019, 58:727-9. 10.2169\/internalmedicine.1155-18","journal-title":"Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer's disease","volume":"11","author":"Stern Y","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012, 11:1006-12. 10.1016\/S1474-4422(12)70191-6","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-1-23","article-title":"Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease","volume":"75","author":"Deslys JP","year":"1994","unstructured":"Deslys JP, Marc\u00e9 D, Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol. 1994, 75:23-7. 10.1099\/0022-1317-75-1-23","journal-title":"J Gen Virol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78358-6","article-title":"Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease","volume":"351","author":"Shibuya S","year":"1998","unstructured":"Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T. Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease. Lancet. 1998, 351:419. 10.1016\/S0140-6736(05)78358-6","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1447-7","article-title":"The influence of PRNP polymorphisms on human prion disease susceptibility: an update","volume":"130","author":"Kobayashi A","year":"2015","unstructured":"Kobayashi A, Teruya K, Matsuura Y, et al.. The influence of PRNP polymorphisms on human prion disease susceptibility: an update. Acta Neuropathol. 2015, 130:159-70. 10.1007\/s00401-015-1447-7","journal-title":"Acta Neuropathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-328x(96)00251-3","article-title":"Gerstmann-Str\u00e4ussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129","volume":"44","author":"Young K","year":"1997","unstructured":"Young K, Clark HB, Piccardo P, Dlouhy SR, Ghetti B. Gerstmann-Str\u00e4ussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. Brain Res Mol Brain Res. 1997, 44:147-50. 10.1016\/s0169-328x(96)00251-3","journal-title":"Brain Res Mol Brain Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.1998.tb00176.x","article-title":"Molecular pathology of fatal familial insomnia","volume":"8","author":"Parchi P","year":"1998","unstructured":"Parchi P, Petersen RB, Chen SG, et al.. Molecular pathology of fatal familial insomnia. Brain Pathol. 1998, 8:539-48. 10.1111\/j.1750-3639.1998.tb00176.x","journal-title":"Brain Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199906)45:6<812::AID-ANA20>3.0.CO;2-2","article-title":"A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein","volume":"45","author":"Hainfellner JA","year":"1999","unstructured":"Hainfellner JA, Parchi P, Kitamoto T, Jarius C, Gambetti P, Budka H. A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol. 1999, 45:812-6. 10.1002\/1531-8249(199906)45:6&lt;812::AID-ANA20&gt;3.0.CO;2-2","journal-title":"Ann Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90578-early-diagnosis-of-v180i-genetic-creutzfeldt-jakob-disease-at-the-preserved-cognitive-function-stage","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:59Z","timestamp":1707507359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90578-early-diagnosis-of-v180i-genetic-creutzfeldt-jakob-disease-at-the-preserved-cognitive-function-stage"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.23374","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,21]]}}}